Newton Biocapital enters as new investor, strong participation of existing investorsPivotal Phase 2b trial initiation in 2027 of BIOX-101 to treat intracerebral hemorrhage BIOX-101 may be ...
We came across a bullish thesis on Markel Group Inc. on The Dutch Investors’s Substack. In this article, we will summarize ...
Spheria Asset Management, an investment management company, released its October 2025 “Spheria Global Opportunities Fund” ...
Daiichi Sankyo continues to advance its pipeline, offering positive catalysts over the next year. Click here to read why ...
In July 2025, the Trump administration approved H20 exports after months of Huang’s lobbying. Nvidia (NASDAQ: NVDA) framed it ...
Breakthrough Properties is raising a $1.5B fund to buy discounted lab assets as the market struggles with high vacancy and ...
The Victorian government's startup support agency is being merged into controversial $2 billion innovation fund Breakthrough ...
Discover how rapid AI advances could trigger an AGI-driven market bubble by 2026, reshape equities, and impact rates.
The Nigerian economy is set for a breakthrough driven by innovation, private-sector partnerships, and regional integration, ...
Overview: Quantum computing has moved from research labs to surging stock valuations and massive investment flows, with some ...
MSCI Inc. (NYSE: MSCI) launched the MSCI All Country Public + Private Equity Index, an innovative daily index that combines ...
Palo Alto Investors LP disclosed in its SEC filing dated November 14 that it increased its holding in Dyne Therapeutics ( DYN 1.08%) by 997,698 shares during the third quarter. The post-trade position ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback